Myriad Genetics, Inc.
Price Action
Technical Summary
WEAKENINGMyriad Genetics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 64), indicating performance broadly in line with the market. Earnings contraction of 284% provides fundamental context to the price action. However, with RSI at 75, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.68 | +25.04% | ABOVE |
| 50 SMA | $4.47 | +30.75% | ABOVE |
| 100 SMA | $4.61 | +26.83% | ABOVE |
| 150 SMA | $5.26 | +11.11% | ABOVE |
| 200 SMA | $5.82 | +0.57% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MYGN in an uptrend right now?
MYGN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is MYGN overbought or oversold?
MYGN's RSI (14) is 75. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is MYGN outperforming the market?
MYGN has a Relative Strength (RS) Rating of 64 out of 99. MYGN is performing about average compared to the market.
Where is MYGN in its 52-week range?
MYGN is trading at $5.85, which is 68% of its 52-week high ($8.59) and 46% above its 52-week low ($3.53).
How volatile is MYGN?
MYGN has a Beta of 1.38 and 52-week volatility of 79%. It's more volatile than the S&P 500 - expect bigger swings.